Qiuling Shi1, Xin Shelley Wang2, Ara A Vaporciyan3, David C Rice3, Keyuri U Popat4, Charles S Cleeland1. 1. Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 2. Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: xswang@mdanderson.org. 3. Department of Thoracic & Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 4. Department of Anesthesiology & Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Abstract
CONTEXT: Few empirical studies have combined the patient's perspective (patient-reported outcomes [PROs]) with clinical outcomes (risk for complications, length of hospital stay, return to planned treatment) to assess the effectiveness of treatment after thoracic surgery for early-stage non-small cell lung cancer (NSCLC). OBJECTIVES: Quantitatively measure PROs to assess functional recovery postsurgery. METHODS: Treatment-naïve patients (N = 72) with NSCLC who underwent either open thoracotomy or video-assisted thoracoscopic surgery (VATS) used the MD Anderson Symptom Inventory (MDASI) to report symptom interference with general activity, work, walking, mood, relations with others, and enjoyment of life for three months after surgery. Functional recovery was defined as interference scores returning to presurgery levels. The MDASI's sensitivity to change in functional recovery over time was evaluated via its ability to distinguish between surgical techniques. RESULTS: Interference scores increased sharply by Day 3 after surgery (all P < 0.001), then returned to baseline levels via different trajectories. Patients who had unscheduled clinic visits during the study period reported higher scores on all six MDASI interference items (all P < 0.05). Compared with the open-thoracotomy group, the VATS group returned more quickly to baseline interference levels for walking (18 vs. 43 days), mood (8 vs. 19 days), relations with others (4 vs. 16 days), and enjoyment of life (15 vs. 41 days) (all P < 0.05). CONCLUSION: Repeated measurement of MDASI interference characterized functional recovery after thoracic surgery for NSCLC and was sensitive to VATS' ability to enhance postoperative recovery. Further study of the clinical applicability of measuring recovery outcomes using PRO-based functional assessment is warranted.
CONTEXT: Few empirical studies have combined the patient's perspective (patient-reported outcomes [PROs]) with clinical outcomes (risk for complications, length of hospital stay, return to planned treatment) to assess the effectiveness of treatment after thoracic surgery for early-stage non-small cell lung cancer (NSCLC). OBJECTIVES: Quantitatively measure PROs to assess functional recovery postsurgery. METHODS: Treatment-naïve patients (N = 72) with NSCLC who underwent either open thoracotomy or video-assisted thoracoscopic surgery (VATS) used the MD Anderson Symptom Inventory (MDASI) to report symptom interference with general activity, work, walking, mood, relations with others, and enjoyment of life for three months after surgery. Functional recovery was defined as interference scores returning to presurgery levels. The MDASI's sensitivity to change in functional recovery over time was evaluated via its ability to distinguish between surgical techniques. RESULTS: Interference scores increased sharply by Day 3 after surgery (all P < 0.001), then returned to baseline levels via different trajectories. Patients who had unscheduled clinic visits during the study period reported higher scores on all six MDASI interference items (all P < 0.05). Compared with the open-thoracotomy group, the VATS group returned more quickly to baseline interference levels for walking (18 vs. 43 days), mood (8 vs. 19 days), relations with others (4 vs. 16 days), and enjoyment of life (15 vs. 41 days) (all P < 0.05). CONCLUSION: Repeated measurement of MDASI interference characterized functional recovery after thoracic surgery for NSCLC and was sensitive to VATS' ability to enhance postoperative recovery. Further study of the clinical applicability of measuring recovery outcomes using PRO-based functional assessment is warranted.
Authors: Nicoleta O Kolozsvari; Giovanni Capretti; Pepa Kaneva; Amy Neville; Franco Carli; Sender Liberman; Patrick Charlebois; Barry Stein; Melina C Vassiliou; Gerald M Fried; Liane S Feldman Journal: Surg Endosc Date: 2012-07-19 Impact factor: 4.584
Authors: Joshua E Rosen; Jacquelyn G Hancock; Anthony W Kim; Frank C Detterbeck; Daniel J Boffa Journal: Ann Thorac Surg Date: 2014-10-18 Impact factor: 4.330
Authors: Hiran C Fernando; Rodney J Landreneau; Sumithra J Mandrekar; Francis C Nichols; Thomas A DiPetrillo; Bryan F Meyers; Dwight E Heron; Shauna L Hillman; David R Jones; Sandra L Starnes; Angelina D Tan; Benedict D T Daly; Joe B Putnam Journal: J Thorac Cardiovasc Surg Date: 2014-11-13 Impact factor: 5.209
Authors: Ethan Basch; Amy P Abernethy; C Daniel Mullins; Bryce B Reeve; Mary Lou Smith; Stephen Joel Coons; Jeff Sloan; Keith Wenzel; Cynthia Chauhan; Wayland Eppard; Elizabeth S Frank; Joseph Lipscomb; Stephen A Raymond; Merianne Spencer; Sean Tunis Journal: J Clin Oncol Date: 2012-10-15 Impact factor: 44.544
Authors: Elizabeth G VanDenKerkhof; Wilma M Hopman; Tanveer Towheed; Rosemary Wilson; John Murdoch; Michael Rimmer; Sherri Schmidt Stutzman; Debbie Tod; Vico Dagnone; David H Goldstein Journal: Pain Res Manag Date: 2006 Impact factor: 3.037
Authors: G Arbane; A Douiri; N Hart; N S Hopkinson; S Singh; C Speed; B Valladares; R Garrod Journal: Physiotherapy Date: 2014-02-12 Impact factor: 3.358
Authors: Nina Shah; Qiuling Shi; Sergio Giralt; Loretta Williams; Qaiser Bashir; Muzaffar Qazilbash; Richard E Champlin; Charles S Cleeland; Xin Shelley Wang Journal: Qual Life Res Date: 2017-12-19 Impact factor: 4.147
Authors: Xing Wei; Hongfan Yu; Wei Dai; Wei Xu; Qingsong Yu; Yang Pu; Yaqin Wang; Jia Liao; Qiang Li; Qiuling Shi Journal: Support Care Cancer Date: 2021-08-27 Impact factor: 3.603
Authors: Larissa A Meyer; Javier Lasala; Maria D Iniesta; Alpa M Nick; Mark F Munsell; Qiuling Shi; Xin Shelley Wang; Katherine E Cain; Karen H Lu; Pedro T Ramirez Journal: Obstet Gynecol Date: 2018-08 Impact factor: 7.661
Authors: Laleh G Melstrom; Andrei S Rodin; Lorenzo A Rossi; Paul Fu; Yuman Fong; Virginia Sun Journal: J Surg Oncol Date: 2020-09-24 Impact factor: 3.454